|
(ÁÖ)ž¾Ø½ºÄ«¿ìÆ® |
0[ÀǾà Á¦Á¶, ÄÚ½º´Ú] ½ÅÁ¦Ç° °³¹ß ÁִϾî ~ ºÎÀå ä¿ë (ÆÀ
°æ±â ¾È¾ç½Ã µ¿¾È±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
2³â¡è |
ä¿ë½Ã |
09.18 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
PV – CR(Clinical research) Associate/¿Ü±¹°èÁ¦¾àȸ
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
2³â¡è |
ä¿ë½Ã |
11.24 |
|
|
(ÁÖ)ºê·£µå¹Ì |
±×·ì °è¿»ç ÀǾà Ç°Áú°ü¸® ¾à»ç
´ëÀü ÀüÁö¿ª, ¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
09.22 |
|
|
¸¶ÀϽºÅæ¼Ä¡ |
Medical Advisor/±¹³»À¯¸íÁ¦¾àȸ»ç
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
˂ȍ |
2³â¡è |
ä¿ë½Ã |
11.02 |
|
|
(ÁÖ)ºê·£µå¹Ì |
±×·ì»ç ¹ÙÀÌ¿ÀÆÊ ÀÓ»ó CRA
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»óº´¸®»ç |
2³â¡è |
ä¿ë½Ã |
10.03 |
|
|
(ÁÖ)ºê·£µå¹Ì |
´ë±â¾÷ Ç°Áú°ü¸® ¾à»ç ´ëÀü±Ù¹«
´ëÀü ´ë´ö±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
10.03 |
|
|
³×¸ðÆÄÆ®³ÊÁîHRG |
À¯¸í ¿Ü±¹°è Á¦¾àȸ»ç PM (»ç¿ø~´ë¸®)
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
11.15 |
|
|
JYpartners |
PD Product Manager
¼¿ï ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
¾à»ç/ÇѾà»ç |
2³â¡è |
ä¿ë½Ã |
03.11 |
|
|
JYpartners |
[[¾à»ç, ÇѾà»ç Çʼö]] CRA 2³â ÀÌ»ó °æ·ÂÀÚ OK
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
PL/PV/PMS/MD |
2³â¡è |
ä¿ë½Ã |
05.06 |
|
|
HRKorea |
ÀÓ»ó°³¹ß (Clinical Research Manager)
¼¿ï ÀüÁö¿ª | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
2³â¡è |
ä¿ë½Ã |
04.11 |
|
|
JYpartners |
[[µ¶ÀÏ°è Åõ¼® Àü¹®±â¾÷]] Sales&Marketing ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
11.02 |
|
|
(ÁÖ) KVC |
±Û·Î¹ú/¿Ü±¹°è Á¦¾à»ç RA / CRA / ¸¶ÄÉÆà PM ¸ðÁý
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Á¦¾à¿µ¾÷/ÀÇ·á±â¿µ¾÷ |
2³â¡è |
ä¿ë½Ã |
10.11 |
|
|
ÇÁ·ÎÇÚÁîÄÚ¸®¾Æ |
À¯¸íÁ¦¾à»ç QA¾à»ç(Ã¥ÀÓÀÚ)
Ãæ³² ÀüÁö¿ª | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
2³â¡è |
ä¿ë½Ã |
04.03 |
|
|
JN Partners |
±Û·Î¹ú CRO PM/CTL(aPM)
¼¿ï ÀüÁö¿ª | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
2³â¡è |
ä¿ë½Ã |
05.25 |
|
|
Å©·¹µ·ÄÁ¼³Æà |
±¹³» ÀÓ»ó½ÃÇè ´ëÇà¾÷ü ÀÇ·á±â±â ¼öÀÔÀÎÇã°¡(RA) ä¿ë
¼¿ï °³²±¸ | ´ëÇÐ(4³â) Á¹¾÷ |
ÀÓ»ó BD/RA/QA |
2³â¡è |
ä¿ë½Ã |
06.19 |
|